Antipsychotic use increasing in children and teens

August 2006
Pharmaceutical Representative;Aug2006, Vol. 36 Issue 8, p12
The article reports on the stable increase in number of patients aged below 20 who received prescriptions for antipsychotic medications in the U.S. for the year 1993 to 2002, based on the report published in the "Archives of General Psychiatry." Data from the national survey of office-based physicians were analyzed by researchers, and revealed 1.2 million outpatient healthcare visits patients in 2002.


Related Articles

  • Legal drug abuse.  // Daughters;Sep/Oct2007, Vol. 12 Issue 5, p3 

    The article discusses the extent of legal drug abuse among teenagers, especially girls, in the U.S. The Substance Abuse and Mental Health Services Administration reported that painkillers such as OxyContin and Vicodin are the most common used drugs among children aged 12-17 years old. Moreover,...

  • Online CME Quiz Questions.  // JAMA: Journal of the American Medical Association;9/28/2011, Vol. 306 Issue 12, p1386 

    An American Medical Association (AMA) continuing medical education (CME) quiz on atypical antipsychotic medications for off-label uses is presented.

  • Olanzapine, risperidone prescribed selectively in The Netherlands.  // PharmacoEconomics & Outcomes News;2/12/2005, Issue 471, p11 

    Discusses research being done on the prescription of olanzapine and risperidone drugs in the Netherlands. Reference to a study by N. S. Breekveldt-Postma and colleagues, published in the January 2005 issue of the "Pharmacoepidemiology and Drug Safety"; Data used in the assessment of the...

  • Changes in Antipsychotic Medication Use after Implementation of a Medicaid Mental Health Carve-Out in the US. Robst, John // PharmacoEconomics;2012, Vol. 30 Issue 5, p387 

    Background: Many Medicaid programmes now offer behavioural healthcare through managed care organizations. Medicaid programmes are concerned about carve-outs because the use of non-included services may rise, limiting the efficiencies anticipated with the implementation of managed care. There...

  • Access to new medications to treat schizophrenia. Mark, Tami L.; Dirani, Riad; Slade, Eric; Russo, Patricia A. // Journal of Behavioral Health Services & Research;Feb2002, Vol. 29 Issue 1, p15 

    Between 1989 and 1997, the Food and Drug Administration approved four new-generation antipsychotic medications for use in the treatment of schizophrenia. This article examines factors associated with the use of new antipsychotic medications as compared with traditional antipsychotic medications...

  • A comparative review of new antipsychotics. Blin, Oliver; Blin, O // Canadian Journal of Psychiatry;Apr1999, Vol. 44 Issue 3, p235 

    Objective: To review the preclinical and clinical properties of various established and putative antipsychotic medications, namely clozapine, risperidone, amisulpride, olanzapine, quetiapine, sertindole, and ziprasidone.Methods: This paper proposes a decision algorithm...

  • Risperidone for the treatment of fecal smearing in a developmentally disabled adult. BRAHM, NANCY C.; FARMER, KEVIN C.; BROWN, ROBERT C. // American Journal of Health-System Pharmacy;2/15/2007, Vol. 64 Issue 4, p382 

    Purpose. The use of risperidone in decreasing fecal smearing behavior as an expression of nonverbal aggression in a developmentally disabled adult is discussed. Summary. A 36-year-old Caucasian man had a history of fecal smearing when he did not get his way or was upset. The patient had profound...

  • Impact of regulatory changes on first- and second-generation antipsychotic drug consumption and expenditure in Italy. Andretta, Margherita; Ciuna, Arcangelo; Corbari, Letizia; Cipriani, Andrea; Barbui, Corrado // Social Psychiatry & Psychiatric Epidemiology;Jan2005, Vol. 40 Issue 1, p72 

    Background: In 1994 a change in drug reimbursement status was implemented in Italy according to cost-effectiveness criteria. The aim of this study was to examine the impact of these changes on the use of antipsychotic (AP) drugs.Methods: Data concerning actual...

  • Consumo y gasto de fármacos antipsicóticos.  // Actas Espanolas de Psiquiatria;mar2005, Vol. 33 Issue 2, p64 

    INTRODUCTION: In recent years, new atypical antipsychotic drugs have been marketed. This study aims to analyze the evolution of the consumption pattern and pharmaceutical cost of the antipsychotic drugs during the last years and the impact that the new atypical antipsychotic drugs have had....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics